A 15-month-old child with recurrent otitis media

JAMA

Volumn 288, Issue 20, 2002, Pages 2589-2598

  Paradise, Jack L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFDINIR; CEFTRIAXONE; CEFUROXIME AXETIL; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIOLOGY; CASE REPORT; COMMON COLD; COST BENEFIT ANALYSIS; DISEASE COURSE; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MALE; MORAXELLA CATARRHALIS; OTITIS MEDIA; PRIORITY JOURNAL; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RHINOVIRUS; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING; TYMPANOSTOMY TUBE;

EID: 0037184435     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.20.2589     Document Type: Article

References (110)

1. Paradise JL, Bernard BS, Colborn DK, Smith CG, Rockette HE, for the Pittsburgh-area Child Development/Otitis Media Study Group. Otitis media with effusion (OME): Highly prevalent and often the forerunner of acute otitis media (AOM) during the first year of life [abstract]. Pediatr Res. 1993;33:121A.
2. Paradise JL. On classifying otitis media as suppurative or nonsuppurative, with a suggested clinical schema. J Pediatr. 1987;111:948-951.
3. Marchant CD, Shurin PA, Turczyk VA, Wasikowski DE, Tutihasi MA, Kinney SE. Course and outcome of otitis media in early infancy: A prospective study. J Pediatr. 1984;104:826-831.
4. Paradise JL. Otitis media in infants and children. Pediatrics. 1980;65:917-943.
5. Pichichero ME, Poole MD. Assessing diagnostic accuracy and tympanocentesis skills in the management of otitis media. Arch Pediatr Adolesc Med. 2001;155:1137-1142
6. Paradise JL, Smith CG, Bluestone CD. Tympanometric detection of middle ear effusion in infants and young children. Pediatrics. 1976;58:198-210.
7. Paradise JL, Rockette HE, Colborn DK, et al. Otitis media in 2253 Pittsburgh-area infants: Prevalence and risk factors during the first two years of life. Pediatrics. 1997;99:318-333.
8. Hoberman A, Paradise JL. Acute otitis media: Diagnosis and management in the year 2000. Pediatr Ann. 2000;29:609-620.
9. Paradise JL. Editorial retrospective: Tympanometry. N Engl J Med. 1982;307:1074-1076.
10. Paradise JL, Smith CG, Sabo DL, et al. Tympanometric detection of middle-ear effusion (MEE) in the first vs the second year of life [abstract]. Arch Pediatr Adolesc Med. 1994;148:P31.
11. Block SL, Mandel E, McLinn S, et al. Spectral gradient acoustic reflectometry for the detection of middle ear effusion by pediatricians. Pediatr Infect Dis J. 1998;17:560-565.
12. Casselbrant ML, Kaleida PH, Rockette HE, et al. Efficacy of antimicrobial prophylaxis and of tympanostomy tube insertion for prevention of recurrent acute otitis media: Results of a randomized clinical trial. Pediatr Infect Dis J. 1992;11:278-286.
13. Kilpi T, Herva E, Kaijalainen T, Syrjänen R, Takala AK. Bacteriology of acute otitis media in a cohort of Finnish children followed for the first two years of life. Pediatr Infect Dis J. 2001;20:654-662.
14. Teele DW, Klein JO, Rosner B. Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study. J Infect Dis. 1989;160:83-94.
15. Howie VM, Ploussard JH, Sloyer J. The "otitis-prone" condition. Am J Dis Child. 1975;129:676-678.
16. Shurin PA, Pelton SI, Donner A, Klein JO. Persistence of middle-ear effusion after acute otitis media in children. N Engl J Med. 1979;300:1121-1123.
17. Coffey JD Jr. Otitis media in the practice of pediatrics. Pediatrics. 1966;38:25-32.
18. Brownlee RC Jr, DeLoache WR, Cowan CC Jr, Jackson HP. Otitis media in children: Incidence, treatment, and prognosis in pediatric practice. J Pediatr. 1969;75:636-642.
19. Sipila M, Karma P, Pukander J, Timonen M, Kataja M. The Bayesian approach to the evaluation of risk factors in acute and recurrent acute otitis media. Acta Otolaryngol. 1988;106:94-101.
20. Casselbrant ML, Mandel EM, Fall PA, et al. The heritability of otitis media: A twin and triplet study. JAMA. 1999;282:2125-2130.
21. Paradise JL, Bluestone CD, Felder H. The universality of otitis media in 50 infants with cleft palate. Pediatrics. 1969;44:35-42.
22. Schwartz DM, Schwartz RH. Acoustic impedance and otoscopic findings in young children with Down's syndrome. Arch Otolaryngol. 1978;104:652-656.
23. Lahikeinen EA. Clinico-bacteriologic studies on acute otitis media: Aspiration of tympanum as a diagnostic and therapeutic method. Acta Otolaryngol (Stockh). 1953;(suppl 107):1-82.
24. Mortimer EA Jr, Watterson RL Jr. A bacteriologic investigation of otitis media in infancy. Pediatrics. 1956;17:359-366.
25. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J. 1992;11:S7-S11.
26. Pitkaranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics. 1998;102:291-295.
27. Heikkinen T, Thint M, Chonmaitree T. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N Engl J Med. 1999;340:260-264.
28. Vesa S, Kleemola M, Blomqvist S, Takala A, Kilpi T, Hovi T. Epidemiology of documented viral respiratory infections and acute otitis media in a cohort of children followed from two to twenty-four months of age. Pediatr Infect Dis J. 2001;20:574-581.
29. Abramson JS, Wheeler JG. Virus-induced polymorphonuclear leukocyte dysfunction: Role in the pathogenesis of bacterial infections. Pediatr Infect Dis J. 1994;13:643-652.
30. Chonmaitree T. Viral and bacterial interaction in acute otitis media. Pediatr Infect Dis J. 2000;19:S24-S30.
31. Riding KH, Bluestone CD, Michaels RH, Cantekin El, Doyle WJ, Poziviak CS. Microbiology of recurrent and chronic otitis media with effusion. J Pediatr. 1978;93:739-743.
32. Qvarnberg Y, Kantola O, Vaitonen H, Vuori E, Salo J, Toivanen M. Bacterial findings in middle ear effusion in children. Otolaryngol Head Neck Surg. 1990;102:118-121.
33. Post JC, Preston RA, Aul JJ, et al. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA. 1995;273:1598-1604.
34. Pitkaranta A, Jero J, Arruda E, Virolainen A, Hayden FG. Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion. J Pediatr. 1998;133:390-394.
35. Gok LJ, Bulut Y, Keles E, Yalcin S, Doymaz MZ. Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions. Int J Pediatr Otorhinolaryngol. 2001;60:49-54.
36. Rayner MG, Zhang Y, Gorry MC, Chen Y, Post JC, Ehrlich GD. Evidence of bacterial metabolic activity in culture-negative otitis media with effusion. JAMA. 1998;279:296-299.
37. Leggiadro RJ. Penicillin- and cephalosporin-resistant Streptococcus pneumoniae: An emerging microbial threat. Pediatrics. 1994;93:500-503.
38. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA. 1994;271:1831-1835.
39. Kaplan SL, for the US Pediatric Multicenter Pneumococcal Surveillance Group. One-year surveillance of systemic pneumococcal infections in children [abstract]. Pediatr Res. 1995;37:179A.
40. Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including comparison of resistance rates since 1994-1995. Antimicrob Agents Chemother. 2001;45:1721-1729.
41. Reinert RR, Al-Lahham A, Lemperle M, et al. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J Antimicrob Chemother. 2002;49:61-68.
42. Takata GS, Chan LS, Shekelle P, Morton SC, Mason W, Marcy SM. Evidence assessment of management of acute otitis media, I: The role of antibiotics in treatment of uncomplicated acute otitis media. Pediatrics. 2001;108:239-247.
43. Cunningham AS. Antibiotics for otitis media: Restraint, not routine. Contemp Pediatr. 1994;11:17-30.
44. Damoiseaux R, van Balen F, Hoes A, Verheij TJM, de Melker RA. Primary care based randomized double blind trial of amoxicillin versus placebo for acute otitis media in children aged under 2 years. BMJ. 2000;320:350-354.
45. Kaleida PH, Casselbrant ML, Rockette HE, et al. Amoxicillin or myringotomy or both for acute otitis media: Results of a randomized clinical trial. Pediatrics. 1991;87:466-474.
46. Burke P, Bain J, Robinson D, Dunleavy J. Acute red ear in children: Controlled trial of non-antibiotic treatment in general practice. BMJ. 1991;303:558-562.
47. Ghaffar FA, Wördemann M, McCracken GH Jr. Acute mastoiditis in children: A seventeen-year experience in Dallas, Texas. Pediatr Infect Dis J. 2001;20:376-380.
48. Lanphear BP, Byrd RS, Auinger P, Hall CB. Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics. 1997;99:el.
49. Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: Management and surveillance in an era of pneumococcal resistance: A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9.
50. Barnett ED, Klein JO. The problem of resistant bacteria for the management of acute otitis media. Pediatr Clin North Am. 1995;42:509-517.
51. Klein JO, McCracken GH Jr. Summary: Role of a new oral cephalosporin, cefdinir, for therapy of infections of infants and children. Pediatr Infect Dis J. 2000;19:S181-S183.
52. Pichichero ME, Marsocci SM, Murphy ML, Hoerger W, Francis AB, Green JL. A prospective observational sudy of 5-, 7-, and 10-day antibiotic treatment for acute otitis media. Otolaryngol Head Neck Surg. 2001;124:381-387.
53. Paradise JL. Short-course antimicrobial treatment for acute otitis media: Not best for infants and young children. JAMA. 1997;278:1640-1642.
54. Cohen R, Levy C, Boucherat M, et al. Five vs ten days of antibiotic therapy for acute otitis media in young children. Pediatr Infect Dis J. 2000;19:458-463.
55. Steele RW, Thomas MP, Begue RE. Compliance issues related to the selection of antibiotic suspensions for children. Pediatr Infect Dis J. 2001;20:1-5.
56. Pankuch GA, Visalli MA, Jacobs MR, Appelbaum PC. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci. Antimicrob Agents Chemother. 1995;39:1499-1504.
57. Ross GH, Hovde LB, Ibrahim KH, Ibrahim YH, Rotschafer JC. Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens. Antimicrob Agents Chemother. 2001;45:2936-2938.
58. Leibovitz E, Piglansky L, Raiz S, Press J, Leiberman A, Dagan R. Bacteriologic and clinical efficacy of one day vs three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children. Pediatr Infect Dis J. 2000;19:1040-1045.
59. Hoberman A, Paradise JL, Wald ER. Tympanocentesis technique revisited. Pediatr Infect Dis J. 1997;16:S25-S26.
60. Cunningham-Rundles C. Disorders of the IgA system. In: Stiehm ER, ed. Immunologic Disorders in Infants and Children. 4th Ed. Philadelphia, Pa: WB Saunders Co; 1996:423-442.
61. Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med. 1985;313:1247-1251.
62. Jorgensen F, Andersson B, Hanson LA, Nylen O, Eden CS. Gamma-globulin treatment of recurrent acute otitis media in children. Pediatr Infect Dis J. 1990;9:389-394.
63. Berman S, Lee B, Nuss R, Roark R, Gicias PC. Immunoglobulin G, total and subclass, in children with or without recurrent otitis media. J Pediatr. 1992;121:249-251.
64. Faden H, Duffy L, Boeve M. Otitis media: Back to basics. Pediatr Infect Dis J. 1998;17:1105-1113.
65. Paradise JL, Elster BA, Tan L. Evidence in infants with cleft palate that breast milk protects against otitis media. Pediatrics. 1994;94:853-860.
66. Shurin PA, Rehmus JM, Johnson CE, et al. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr. 1993;123:801-810.
67. Simoes EA, Groothuis JR, Tristram DA, et al. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr. 1996;129:193-196.
68. Stool SE, Berg AO, Berman S, et al. Otitis Media With Effusion in Young Children. Clinical Practice Guideline 12. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service; 1994. AHCPR Publication No. 94-0622.
69. Bess FH, Paradise JL. Universal screening for infant hearing impairment [reply to letters]. Pediatrics. 1994;94:959-963.
70. Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis and in treating otitis media with effusion: A meta-analytic attempt to resolve the brouhaha. JAMA. 1993;270:1344-1351.
71. Boken DJ, Chartrand SA, Goering RV, Kruger R, Harrison DJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J. 1995;14:879-884.
72. Ciftci E, Dogru U, Aysev D, Ince E, Guriz H, Aysev D. Investigaion of risk factors for penicillin-resistant Streptococcus pneumoniae carriage in Turkish children. Pediatr Int. 2001;43:385-390.
73. Mandel EM, Rockette HE, Bluestone CD, Paradise JL, Nozza RJ. Myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Arch Otolaryngol Head Neck Surg. 1989;115:1217-1224.
74. Mandel EM, Rockette HE, Bluestone CD, Paradise JL, Nozza RJ. Efficacy of myringotomy with and without tympanostomy tubes for chronic otitis media with effusion. Pediatr Infect Dis J. 1992;11:270-277.
75. Capra AM, Lieu TA, Black SB, Shinefield HR, Martin KE, Klein JO. Costs of otitis media in a managed care population. Pediatr Infect Dis J. 2000;19:354-355.
76. Paradise JL. On tympanostomy tubes: Rationale, results, reservations and recommendations. Pediatrics. 1977;60:86-90.
77. Lildholdt T. Ventilation tubes in secretory otitis media: A randomized, controlled study of the course, the complications, and the sequelae of ventilation tubes. Acta Otolaryngol Suppl. 1983;398:1-28.
78. Tos M, Poulsen G. Secretory otitis media: Late results of treatment with grommets. Arch Otolaryngol. 1976;102:672-675.
79. Ah-Tye C, Paradise JL, Colborn DK. Otorrhea in young children after tympanostomy-tube placement for persistent middle-ear effusion: Prevalence, incidence, and duration. Pediatrics. 2001;107:1251-1258.
80. Sederberg-Olsen JF, Sederberg-Olsen AE, Jensen AM. Late results of treatment with ventilation tubes for secretory otitis media in ENT practice. Acta Otolaryngol. 1989;108:448-455.
81. Kay DJ, Nelson M, Rosenfeld RM. Meta-analysis of tympanostomy tube sequelae. Otolaryngol Head Neck Surg. 2001;124:374-380.
82. Paradise JL, Feldman HM, Campbell TF, et al. Effect of early or delayed insertion of tympanostomy tubes for persistent otitis media on developmental outcomes at the age of three years. N Engl J Med. 2001;344:1179-1187.
83. Bluestone CD, Cantekin EI, Beery QC, et al. Functional eustachian tube obstruction in acquired cholesteatoma and related conditions. In: McCabe BF, Sadé J, Abramson M, eds. Cholesteatoma: First International Conference. Birmingham, Ala: Aesculapius; 1977:325-335.
84. Sadé J, Avraham S, Brown M. Dynamics of atelectasis and retraction pockets. In: Sadé J, ed. Cholesteatoma and Mastoid Surgery. Amsterdam, the Netherlands: Kugler Publications; 1982:267-281.
85. Paparella MM, Oda M, Hiraida F, Brady D. Pathology of sensorineural hearing loss in otitis media. Ann Otol Rhinol Laryngol. 1972;81:632-647.
86. Paradise JL. Does early-life otitis media result in lasting developmental impairment? why the question persists, and a proposed plan for addressing it. Adv Pediatr. 1992;39:157-165.
87. Rosenfeld RM, Post JC. Meta-analysis of antibiotics for the treatment of otitis media with effusion. Otolaryngol Head Neck Surg. 1992;106:378-386.
88. Mandel EM, Rockette HE, Bluestone CD, Paradise JL, Nozza RJ. Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children: Results of a double-blind randomized trial. N Engl J Med. 1987;316:432-437.
89. Paradise JL. Managing otitis media: A time for change. Pediatrics. 1995;96:712-715.
90. Dowell SF, Marcy SM, Phillips WR, Gerber MA, Schwartz B. Otitis media: Principles of judicious use of antimicrobial agents. Pediatrics. 1998;101(suppl):165-171.
91. American Academy of Pediatrics. Clinical practice guideline: Management of sinusitis. Pediatrics. 2001;108:798-808.
92. Bluestone CD, Klein JO. Otitis media, atelectasis, and eustachian tube dysfunction. In: Bluestone CD, Stool SE, Kenna MA, eds. Pediatric Otolaryngology, 3rd Ed. Philadelphia, Pa: WB Saunders Co; 1996:495-497.
93. Paradise JL, Bluestone CD, Rogers KD, et al. Efficacy of adenoidectomy for recurrent otitis media in children previously treated with tympanostomy-tube placement: Results of parallel randomized and nonrandomized trials. JAMA. 1990;263:2066-2073.
94. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;19:187-195.
95. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-499.
96. Joloba ML, Windau A, Bajaksouzian S, Appelbaum PC, Hausdorff WP, Jacobs MR. Pneumococcal conjugate vaccine serotypes of Streptococcus pneumoniae isolates and the antimicrobial susceptibility of such isolates in children with otitis media. Clin Infect Dis. 2001;33:1489-1494.
97. Kyaw MH, Clarke S, Jones IG, Campbell H. Noninvasive pneumococcal disease and antimicrobial resistance: Vaccine implications. Epidemiol Infect. 2002;128:21-27.
98. Heikkinen T, Ruuskanen O, Waris M, Zieger T, Arola M, Halonen P. Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child. 1991;145:445-448.
99. Clements DA, Langdon L, Bland C, Emmanuel W. Influenza A vaccine decreases incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995;149:1113-1117.
100. Belshe RB, Mendelman PM, Treanor J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influerza virus vaccine in children. N Engl J Med. 1998;338:1405-1412.
101. Marchisio P, Cavagna R, Maspes B, et al. Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children. Clin Infect Dis. 2002;35:168-174.
102. Fletcher RH, Fletcher SW, Wagner EH. Clinical Epidemiology: The Essentials. 2nd Ed. Baltimore, Md: Williams & Wilkins; 1988:208-225.
103. Maw R, Wilks J, Harvey I, Peters TJ, Golding J. Early surgery compared with watchful waiting for glue ear and effect on language development in preschool children: A randomised trial. Lancet. 1999;353:960-963.
104. Rovers MM, Straatman H, Ingels K, van der Wilt G-J, van den Broek P, Zielhuis GA. The effect of ventilation tubes on language development in infants with otitis media with effusion: A randomized trial. Pediatrics. 2000;106:e42
105. Prellner K, Fogle-Hansson M, Jørgensen F, Kalm O, Kamme C. Prevention of recurrent acute otitis media in otitis-prone children by intermittent prophylaxis with penicillin. Acta Otolaryngol (Stockh) 1994;114:182-187.
106. Berman S, Nuss R, Roark R, Huber-Navin C, Grose K, Herrera M. Effectiveness of continuous vs intermittent amoxicillin to prevent episodes of otitis media. Pediatr Infect Dis J. 1992;11:63-67.
107. Heikkinen T, Ruuskanen O, Ziegler T, Waris M, Puhakka H. Short-term use of amoxicillin-clavulanate during upper respiratory tract infection for prevention of acute otitis media. J Pediatr. 1995;126:313-316.
108. Zola H. The development of antibody responses in the infant. Immunol Cell Biol. 1997;75:587-590.
109. Vogler RC, Ii FJw, Pilgram TK. Age-specific size of the normal adenoid pad on magnetic resonance imaging. Clin Otolaryngol. 2000;25:392-395.
110. Bluestone CD, Klein JO. Otitis media, atelectasis, and eustachian tube dysfunction. In: Bluestone CD, Stool SE, Kenna MA, eds. Pediatric Otolaryngology, Vol 1. 3rd Ed. Philadelphia, Pa: WB Saunders Co; 1996:388-582.